William D. Chey

ORCID: 0000-0002-4584-4026 · 2 papers in corpus · active 2020

Study types

  • article 2

Condition tags

  • irritable_bowel_syndrome 2
article 2020
Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
·doi:10.17615/n007-6y73

BACKGROUND: Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel syndrome with constipation (IBS-C) in wom…

article 2020
S0492 Tegaserod 6 Mg BID for Treating Abdominal Pain and Bloating in Women With Irritable Bowel Syndrome With Constipation but Without Cardiovascular Risk Factors: A Pooled Analysis of 4 Clinical Trials
·doi:10.14309/01.ajg.0000704016.06499.ec

INTRODUCTION: Irritable bowel syndrome with constipation (IBS-C) is characterized by symptoms that extend beyond bowel movement frequency and are worrisome to most patients (e.g., abdominal pain, bloating). The 5-HT4 receptor agonist tegase…